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ABSTRACT
Systemic inflammatory response syndrome (SIRS) occurs in almost all patients whom 
undergo open heart surgery causes the increase its morbidity and mortality. The effect 
of pre- and intraoperative methylprednisolone administration combined with hemofilter 
application in cardiopulmonary bypass machine in the reduction of SIRS incidence 
remains controversial. This study aimed to evaluate the effect pre- and intraoperative 
methylprednisolone administration combined with hemofilter on SIRS incidence after 
open heart surgery. This was an experimental study using prospective randomized open-
blinded evaluation (PROBE) design. Ninety-five patients from Dr. Sardjito General Hospital, 
Yogyakarta, and Dr. Cipto Mangunkusumo General Hospital, Jakarta, who had open heart 
surgery within the period of December 2011 to May 2012 were enrolled in this study. 
The patients were randomly allocated into two groups i.e. Group A (48 patients) received 
pre-; intra-; and postoperative methylprednisolone (15; 5 and 5 mg/kg BW, respectively) 
and hemofilter and Group B (47 patients) just received intra- and postoperative 
methylprednisolone (15 and 5 mg/kg BW). The SIRS incidence was evaluated in 3; 24; 
48 and 72 hours post surgery. This study showed that the SIRS incidence in Group B 
at 3 (OR= 0.12; 95%CI=0.03-0.39; p< 0.001) and 24 (OR= 0.38; 95%CI=0.14-
0.996; p< 0.031)  hours postoperative were significantly higher than that in Group 
A. In conclusion, pre- and intraoperative methylprednisolone administration combined 
hemofilter significantly decrease the SIRS incidence post open heart surgery.
ABSTRAK
Systemic inflammatory response syndrome (SIRS) terjadi pada hampir semua pasien 
yang menjalani bedah jantung terbuka sehingga menyebabkan meningkatnya morbiditas 
dan mortalitas. Pemberian metilprednisolon pra- dan intraoperatif bersama hemofilter 
pada mesin cardiopulmonary bypass masih kontroversial dalam mengurangi risiko 
SIRS. Penelitian ini bertujuan untuk mengkaji efek pemberian metilprednisolon pre- dan 
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intraoperasi bersama penggunaan hemofilter terhadap kejadian SIRS paska bedah jantung 
terbuka. Penelitian ini merupakan penelitian eksperimental dengan rancangan prospective 
randomized open-blinded evaluation (PROBE). Sebanyak 95 pasien yang menjalni bedah 
jantung terbuka di RSUP Dr. Sardjito, Yogyakarta dan RSUPDr. Cipto Mangunkusumo, 
Jakarta, selama Desember 2011 hingga Mei 2012 diikutsertakan dalam penelitian ini. 
Pasien dibagi menjadi 2 kelompok yaitu Kelompok A (48 pasien) menerima metilprednisolon 
pre-, intra- dan pascaoperasi dengan dosis berturut-turut 15, 5 dan 5 mg/kg BB serta 
Keompok B menerika metilprednisolon intra- dan pascaoperasi dengan dosis 15 dan 5 mg/
kg BB. Kejadian SIRS diamati pada jam ke 3, 24, 48 dan 72 pascaoperasi. Hasil penelitian 
menunjukkan kejadian SIRS pada Kelompok B pada 3 jam (OR= 0,12; 95%CI=0,03-0,39; 
p< 0,001) and 24 jam (OR= 0,38; 95%CI=0,14-0,996; p< 0,031) pascaoperasi lebih 
tinggi secara bermakna dibandingkan pada Kelompok A. Dapat disimpulkan, pemberian 
metilprednisolon pre- dan pascaoperasi bersama dengan penggunaan hemofilter secara 
bermakna menurunkan kejadian SIRS pasa operasi jantung terbuka.   
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INTRODUCTION
Open heart surgery is well-accepted 
treatment for ischemic, valvular or congenital 
heart diseases, with low morbidity and 
mortality. Although it is fundamental for 
most heart opertions, it is associated with a 
complex Systemic Inflammation Response 
Syndrome (SIRS). The SIRS occurs in 
almost all patients whom undergo open 
heart surgery.1-3 The clinical course of SIRS 
varies greatly and is often difficult to predict.1 
Sometimes with subtle SIRS can be clinically 
harm the patients.4 Moreover, patients with 
SIRS can progress to sepsis, septic shock, and 
may progress to multi-organ failure, which 
progression into death.1,2,5 
To prevent the SIRS incidence after open 
heart surgery, intraoperative methylprednisolone 
administration is performed by mixed in a liquid 
circuit priming cardiorespiratory machine before 
the blood circulation outside the body started. The 
intraoperative methylprednisolone administration 
in open heart surgery was first introduced by 
Raploge et al.6 in 1966. Furthermore, it is used 
as a standard protocol to prevent SIRS due to 
the use of cardiopulmonary bypass machine.7 
However, further studies demonstrated the 
limitations of this protocol. The widespread 
use of corticosteroids to prevent detrimental 
physiologic alterations associated with 
activation of the SIRS on patients undergoing 
open heart surgery has been reported. However, 
the clinical evidences of the use corticosteroids 
to prevent the decline pulmonary function 
and to improve the systemic edema does not 
support. In contrast, the use corticosteroids 
can increase postoperative blood glucose 
levels and prolong the surgical wound healing 
lead to morbidity and mortality can not be 
minimized.8 In addition, the ability of steroids 
to improve clinical outcomes in pediatric 
cardiac surgery patients was less clear and 
may actually be harmful.9,10 
To overcome the limitations of the 
intraoperative methylprednisolone use to 
prevent SIRS, some protocols have been applied. 
A protocol using combination of intraoperative 
and preoperative methylprednisolone adminis-
tration to reduce of the SIRS incidence after 
open heart surgery has been developed and 
used.  Furthermore, the use of hemofilter in 
cardiopulmonary bypass machine has been 
initiated in 1980s. Hemofiltration during open 
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heart surgery served as an effective method for 
increased red blood cells and plasma protein 
concentration and for allowing volume and 
edema control.11  The use of hemofilter reduced 
post-cardiopulmonary bypass inflammatory 
response and immunologic activation associated 
with improvements in postoperative pulmonary, 
cardiac and neurologic function.12,13 In this 
study we reported the effect of combination 
between preoperative and intraoperative 
methylprednisolone administration as well as 
the use of hemofilter on the incidence of post-
operative SIRS on patients underwent open 
heart surgery.
MATERIALS AND METHODS
Patients and study design
This was an experimental study with 
Prospective Randomized Open-Blinded 
Evaluation (PROBE) design conducted in Dr. 
Sardjito General Hospital, Yogyakarta and 
Dr. Cipto Mangunkusumo General Hospital, 
Jakarta during the period of December 2011 
until May 2012. The subjects were all patients 
who aged more than 18 years old, had an heart 
defect, underwent open-heart surgery and 
patients as well as their family were willing to 
participate in this study by signing an inform 
consent. Patients with a heart defect who had 
a chronic pulmonary diseases, ever underwent 
lung surgery, ever underwent aorta thoracalis 
surgery, ever underwent open heart surgery 
and abnormal left ventricular function were 
excluded from this study. The subjects were 
randomly allocated into two groups i.e. Group 
A were the patients who treated with pre-; 
intra-; and postoperative methylprednisolone 
(15; 5 and 5 mg/kg BW, respectively), pre- 
and postoperative methylprednisolone (5 
mg/kg BW), and hemofilter and Group B 
were the patients who treated with intra- 
and postoperative methylprednisolone (15 
and 5 mg/kg BW, respectively).  Protocol of 
the study was approved by the Medical and 
Health Research Ethics Committee, Faculty 
of Medicine, Universitas Gadjah Mada/
Dr. Sardjito General Hospital, Yogyakarta 
(#KE/FK/768/EC) and Faculty Medicine/
Dr. Cipto Mangunkusumo General Hospial, 
Universitas Indonesia, Jakarta (#364/PT02.
FK/ETIK/2012). 
Protocol of study
After approval by the ethics committee 
and written informed consent,  the eligible 
patients undergoing open heart surgery were 
enrolled in the study. After premedication with 
medazolam 0.05 mg/kg BW, fentanyl 1 µg/
kg BW, dobutamine 5-10 µg/kg BW/min and 
nitroglycerin 0.5 µg/kg BW/min for patients 
undergoing coronary bypass surgery, general 
anesthesia was induced with etomidate lipuro 
0.2-0.4 mg/kg BW and rocuronium 0.5-0.6 
mg/kg BW as muscle relaxant. Anesthesia was 
maintained by continuous intravenous infusion 
of propofol 1 mg/kg BW/h and fentanyl 2 µg/
kg BW. Right before induction, the patients 
of Group A were administered preoperative 
intravenous methylprednisolone 5 mg/kg. The 
ECG, EEG, arterial blood oxygen saturation, 
pulmonary artery pressure, aesophageal and 
rectal temperature and arterial blood pressure 
were monitored continuously by using 
Marquette Solar 8000 Patient Monitor. 
After induction, the patients of both 
groups (Group A and B) were administered 
intraoperative intravenous methylprednisolone 
15 mg/kg BW by mixing with priming fluid of 
heart-lung machine. Furthermore, hemofilter 
device was attached to heart-lung machine 
circuit and activated when the rewarming 
process had been conducted for the patients 
of Group A. The amount of fluid aspirated 
from the intravascular space was 15 mL/kg 
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BW. Open heart surgery was performed in a 
standardized fashion in the hospitals. After 
the surgery, all patient of both groups (Group 
A and B) were administered postoperative 
methylprednisolone intravenous 5 mg/kg 
BW  for 48 hour.  Blood samples of the both 
groups were collected before the surgery for 
hemoglobin, ureum, creatinine, albumin, 
blood glucose, kalium, natrium, calcium, and 
magnesium levels baseline examinations. 
The white blood cell and neutrophil counts 
were also examined from preoperative blood 
samples. Furthermore, it was continously 
collected in 3; 24; 48 and 72 hours post 
surgery for white blood cell count, neutrophil 
and PaCO2 examinations.
The SIRS incidence was evaluated in 
3; 24; 48 and 72 hours post surgery. The 
diagnosis of SIRS was made if the subject met 
two or more of these criterias followed 1) body 
temperature less than 36oC or more than 38 oC; 
2) heart rate greater than 90 beats per minute; 
3) respiratory rate more than 20 breaths per 
minute or PaCO2 less than 32mmHg, and 
white blood cell count greater than 12000 cell/
mm3 or neutrophil count increased more than 
10% from its normal value. 
Statistical analysis
Data were presented as mean ± standard 
deviation (SD) and compared using analysis 
of variance (ANOVA) continued using t-test 
for parametric data. For non-parametric data 
were compared using Chi-square or Fisher 
exact test. Significant difference was defined 
as  p < 0.05.
RESULTS
Ninety-six patients who met inclusion and 
exclusion criteria were recruited during the 
study. However, one of the patients was not 
analyzed due to the data were not complete. 
Furthermore,  48 patients of the Group A, and 
47 patients of the Group B were analyzed. 
The characteristics of the patients of the 
both group were not significantly different (p 
>0.05) (TABLE 1). 
The SIRS incidence in the both groups 
was evaluated at 3, 24, 48, and 72 hours 
postoperative. The SIRS incidence in the 
Group A was significantly lower than that in 
Group B at 3 and 24 hours postoperative (p < 
0.01) (TABLE 2 and 3). However, the SIRS 
incidence in Group A was not significantly 
different compared to that in Group B at 48 
and 72 hours postoperative (p > 0.05) (TABLE 
4). It was demonstrated that the pre-, intra- 
and postoperative combined with hemofilter 
could protect the SIRS incidence at 3 and 24 
postoperative. 
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TABLE 1. Baseline characteristic of the patients with open heart surgery
Variable
Group A [n (%)]
[48 (50.5)]
Group B [n (%)]
[47 (49.5)]
Total [n (%)]
[95 (100)] p
Age (Years)
> 30 39 (81.3) 41(87.2) 80 (84.2)
0.451
< 30 9 (18.7) 6 (12.8) 15 (15.8)
Sex
Male 26 (54.2) 22 (46.8) 48 (50.5)
0.473
Female 22 (45.8) 25 (53.2) 47(49.5)
NYHA class
Two 33 (68.8) 27 (57.4) 60 (63.2)
0.239Three 15 (31.3) 18 (38.3) 33 (34.7)
Four 0 2 (4.3) 2 (2.1)
Hb 
Abnormal 3 (6.7) 1 (2.3) 4 (4.5)
0.617
Normal 42 (93.3) 42 (97.7) 84 (95.5)
Creatinine
Abnormal 19 (42.2) 15 (35.7) 34 (39.1)
0.534
Normal 26 (57.8) 27 (64.3) 53 (60.9)
Ureum
Abnormal 7 (16.3) 2 (4.7) 9 (10.5)
0.156
Normal 36 (83.7) 41 (95.3) 77 (89.5)
Albumin 
Abnormal 3 (6.7) 4 (9.5) 7 (8)
0.707
Normal 42 (93.3) 38 (90.5) 80 (92)
Blood glucose
level
Abnormal 3 (6.8) 7 (16.7) 10 (11.6)
0.191
Normal 41 (93.2) 35 (83.3) 76 (88.4)
Kalium
Abnormal 4 (9.3) 2 (4.8) 6 (7.1)
0.676
Normal 39 (90.7) 40 (95.2) 79 (92.9)
Natrium 
Abnormal 5 (11.6) 2 (4.8) 7 (8.2)
0.433
Normal 38 (88.4) 40 (95.2) 78 (91.8)
Magnesium 
Abnormal 2 (4.9) 6 (16.7) 8 (10.4)
0.137
Normal 39 (95.1) 30 (83.3) 69 (89.6)
Calcium 
Abnormal 0 3 (8.3) 3 (4)
0.106
Normal 39 (100) 33 (91.7) 72 (96)
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TABLE 2. The incidence [n (%)] of SIRS at 3 hours post surgery
Treatment Group
Yes
66 (69.5)
No
29 (30.5)
Total
95 (100)
OR (95% CI) p
Group A 24 (36.4) 24 (82.8) 48 (50.5)
0.12  (0.03-0.39) <0.001
Group B 42 (63.6) 5 (17.2) 47 (49.5)
RRR= 0.44 (0.245-0.585); ARR= 0.394 (0.212-0.542); NNT= 2 (5-2)
TABLE 3. The incidence of SIRS at 24 hours post surgery
Treatment Group
Yes
58 (63.7)
No
33 (36.3)
Total
91 (100)
OR (95% CI) p
Group A 25 (43.1) 22 (66.7) 47 (51.6)
0.38  (0.14-1.00) <0.001
Group B 33 (56.9) 11 (33.3) 44 (48.4)
RRR=0.291 (0.025-0.484); ARR=0.218 (0.021-0.392); NNT= 4 (49-3)
Table 4. The incidence of post-operative SIRS in group A and group B
Treatment
Group
Hours post-operative
3-hours (n=66) 24-hours (n=58) 48-hours  (n=33) 72-hours (n=9)
SIRS 
[n (%)]
OR
(95% 
CI)
p SIRS 
[n (%)]
OR 
(95%
CI)
p SIRS (n)
OR
 (95% 
CI)
p SIRS 
[n (%)]
OR 
(95%
CI)
p
Group A 24 (36.4)
8.40 
(2.835-
24.89)
<0.001
25 (43.1)
2.64 
(1.08-
6.44)
0.031
17 (51.5)
1.01 
(0.427-
2.391)
0.980
6 (66.7)
0.50 
(0.12-
2.155)
0.485
Group B 42 (63.6) 33 (56.9) 16 (48.5) 3 (33.3)
DISCUSSION
In this study, the lower SIRS incidence 
in group A than group B was observed. Some 
factors are associated with SIRS in open heart 
surgery including surgical trauma and extra-
corporal circulation.2 Major surgical trauma in 
open heart surgery procedure is thoracotomy 
and surgical incisions on blood vessels and 
heart. The major surgical trauma can trigger 
cytokine release to the blood circulation 
and lead to SIRS.14-16 Methylprednisolone 
administration may inhibit the synthesis 
of cytokines. Moreover, it may stabilize 
pro-inflammatory and anti-inflammatory 
cytokines which results in reducing risk of 
SIRS.17,18 Extra corporeal circulations in 
cardiopulmonary bypass machine allows 
contact of blood and inner machine circuit 
which will affect complement system, 
platelet, endothelial cell, neutrophil, and 
monocyte. Circulating cytokines can activate 
those components resulting in SIRS.19,20 
Hemofilter installment in cardiopulmonary 
bypass machine is reported to reduce the level 
of circulating cytokine21 moreover reduce the 
risk of SIRS incidence.
The most significantly different in SIRS 
incidence between Group A and Group B 
was observed at 3 hours post surgery in 
this study. This result demonstrated that 
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the optimal effect of methylprednisolone 
in the decrease SIRS incidence occurred 
mostly at 3 hours postsurgery. The maximum 
serum pro-inflammatory cytokines and 
complement levels in patients undergoing 
cardiopulmonary bypass was achieved 3 
hours after the extracorporal circulation 
stopped.22 It means that the highest SIRS 
incidence can be occurred at several hours 
after the extracorporal circulation stopped 
and when the high serum pro-inflammatroy 
cytokines achieved. Furthermoore, the 
serum pro-inflammatory declines gradually 
during 24 hours postsurgery followed by the 
decrease of SIRS incidence. In addition, with 
the methyprednisoone half life of 6-12 hours 
and its time peak serum concentration of 
1-2 hours23, the maximal protection effect of 
methylprednisolone against SIRS is achieved 
at several hours after administration.
No difference of SIRS incidence between 
group A and B at 48 and 72 hours postsurgery 
was observed in this study. It might be 
explained by the fact that after 48 and 72 hours 
postsurgery, the serum methylprednisolone 
concentration does not achieved therapeutic 
range concentration, therefore it does not have 
protection effect against SIRS. Furthermore, 
the use of hemofilter has been stopped. 
CONCLUSION
In conclusion,  pre- and intraoperative 
methylprednisolone administration combined 
the use hemofilter in open heart surgery 
significantly decrease the SIRS incidence.
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